277 related articles for article (PubMed ID: 21394649)
1. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.
Matsuyama A; Hisaoka M; Nagao Y; Hashimoto H
Virchows Arch; 2011 May; 458(5):583-92. PubMed ID: 21394649
[TBL] [Abstract][Full Text] [Related]
2. PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study.
Matsuyama A; Hisaoka M; Hashimoto H
Virchows Arch; 2011 Nov; 459(5):539-45. PubMed ID: 21927843
[TBL] [Abstract][Full Text] [Related]
3. HMGA2-WIF1 Rearrangements Characterize a Distinctive Subset of Salivary Pleomorphic Adenomas With Prominent Trabecular (Canalicular Adenoma-like) Morphology.
Agaimy A; Ihrler S; Baněčková M; Costés Martineau V; Mantsopoulos K; Hartmann A; Iro H; Stoehr R; Skálová A
Am J Surg Pathol; 2022 Feb; 46(2):190-199. PubMed ID: 34324456
[TBL] [Abstract][Full Text] [Related]
4. PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland.
Matsuyama A; Hisaoka M; Hashimoto H
Pathol Int; 2012 Jan; 62(1):1-7. PubMed ID: 22192798
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
[TBL] [Abstract][Full Text] [Related]
6. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
[TBL] [Abstract][Full Text] [Related]
7. Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB.
Afshari MK; Fehr A; Nevado PT; Andersson MK; Stenman G
Genes Chromosomes Cancer; 2020 Nov; 59(11):652-660. PubMed ID: 32654217
[TBL] [Abstract][Full Text] [Related]
8. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
9. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry.
Martins C; Fonseca I; Roque L; Pereira T; Ribeiro C; Bullerdiek J; Soares J
Mod Pathol; 2005 Aug; 18(8):1048-55. PubMed ID: 15920557
[TBL] [Abstract][Full Text] [Related]
10. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
11. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
Bahrami A; Dalton JD; Shivakumar B; Krane JF
Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.
El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S
Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520
[TBL] [Abstract][Full Text] [Related]
13. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
14. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
15. Some pleomorphic adenomas of the breast share PLAG1 rearrangements with the analogous tumour of the salivary glands.
Ma S; Zhao D; Liu Y; Rohr J; Zhang F; Ma Y; Gong L; Shi H; Wang Y; Fan L; Qin J; Wang Z; Guo S
Histopathology; 2021 Dec; 79(6):1030-1039. PubMed ID: 34292619
[TBL] [Abstract][Full Text] [Related]
16. Metastasizing Pleomorphic Adenoma: Recurrent PLAG1/HMGA2 Rearrangements and Identification of a Novel HMGA2-TMTC2 Fusion.
Wasserman JK; Dickson BC; Smith A; Swanson D; Purgina BM; Weinreb I
Am J Surg Pathol; 2019 Aug; 43(8):1145-1151. PubMed ID: 31094927
[TBL] [Abstract][Full Text] [Related]
17. SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors.
Macagno N; Kervarrec T; Thanguturi S; Sohier P; Pissaloux D; Mescam L; Jullie ML; Frouin E; Osio A; Faisant M; Le Loarer F; Cribier B; Calonje E; Luna EVE; Massi D; Goto K; Nishida H; Paindavoine S; Houlier A; Tantot J; Benzerdjeb N; Tirode F; De la Fouchardière A; Battistella M
Mod Pathol; 2024 Mar; 37(3):100430. PubMed ID: 38266920
[TBL] [Abstract][Full Text] [Related]
18. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic adenoma gene 1 is expressed in cultured benign and malignant salivary gland tumor cells.
Queimado L; Lopes C; Du F; Martins C; Bowcock AM; Soares J; Lovett M
Lab Invest; 1999 May; 79(5):583-9. PubMed ID: 10334569
[TBL] [Abstract][Full Text] [Related]
20. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
